We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
1
Zoetis
ZTS
$31.6B
$474M 2.57%
2,864,899
+564,851
+25% +$91.9M
TMO icon
2
Thermo Fisher Scientific
TMO
$211B
$404M 2.19%
867,394
+347,974
+67% +$163M
TFX icon
3
Teleflex
TFX
$5.85B
$363M 1.97%
882,919
+133,883
+18% +$49.4M
SPY icon
4
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$353M 1.91%
944,100
+468,300
+98% +$166M
RGEN icon
5
Repligen
RGEN
$7.44B
$284M 1.54%
1,481,280
+573,604
+63% +$104M
MSFT icon
6
Microsoft
MSFT
$2.84T
$245M 1.33%
1,103,068
-49,502
-4% -$10.6M
SPY icon
7
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$242M 1.31%
646,700
+540,600
+510% +$192M
AMZN icon
8
Amazon
AMZN
$2.5T
$235M 1.27%
1,443,140
-454,280
-24% -$72.5M
IWM icon
9
PUT
iShares Russell 2000 ETF
IWM
$80.9B
$229M 1.24%
1,165,700
+72,200
+7% +$12.6M
CCL icon
10
Carnival Corporation Ltd
CCL
$36.1B
$226M 1.22%
10,432,763
+7,718,809
+284% +$137M
BHVN
11
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$219M 1.19%
2,556,552
+28,702
+1% +$2.43M
TRU icon
12
TransUnion
TRU
$14.8B
$216M 1.17%
2,174,778
+177,902
+9% +$16.3M
BIO icon
13
Bio-Rad Laboratories Class A
BIO
$8.42B
$215M 1.17%
369,411
+88,844
+32% +$50.6M
CRL icon
14
Charles River Laboratories
CRL
$10.9B
$213M 1.15%
852,914
+39,637
+5% +$9.44M
SLV icon
15
PUT
iShares Silver Trust
SLV
$28.1B
$172M 0.93%
7,019,100
+5,999,900
+589% +$136M
MNST icon
16
Monster Beverage
MNST
$91.4B
$159M 0.86%
3,441,574
+541,468
+19% +$22.8M
BABA icon
17
Alibaba
BABA
$269B
$157M 0.85%
675,712
+18,198
+3% +$5.05M
HYG icon
18
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$155M 0.84%
1,777,900
+1,286,500
+262% +$110M
AAPL icon
19
Apple
AAPL
$4.89T
$143M 0.78%
1,081,470
+320,433
+42% +$38.5M
GLD icon
20
PUT
SPDR Gold Trust
GLD
$131B
$143M 0.78%
804,500
-790,400
-50% -$139M
GOOGL icon
21
Alphabet (Google) Class A
GOOGL
$3.91T
$140M 0.76%
1,592,800
-2,052,840
-56% -$173M
BIIB icon
22
Biogen
BIIB
$29.9B
$127M 0.69%
519,853
+403,268
+346% +$104M
A icon
23
Agilent Technologies
A
$39.1B
$127M 0.69%
1,071,213
-1,235,472
-54% -$137M
MA icon
24
Mastercard
MA
$477B
$126M 0.68%
351,991
+77,525
+28% +$25.8M
GH icon
25
Guardant Health
GH
$19.5B
$122M 0.66%
946,882
+15,300
+2% +$1.76M

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.